5/28
01:17 am
onvo
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/21
08:05 am
onvo
Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease
Low
Report
Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease
5/20
03:00 am
onvo
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/14
11:13 am
onvo
Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) [Yahoo! Finance]
Medium
Report
Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) [Yahoo! Finance]
5/14
11:08 am
onvo
Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) [Financial Post (Toronto, Ontario, Canada)]
5/14
11:00 am
onvo
Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)
Medium
Report
Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)
5/12
03:02 am
onvo
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/8
08:11 pm
onvo
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering [Yahoo! Finance]
Medium
Report
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering [Yahoo! Finance]
5/8
08:07 pm
onvo
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering [Financial Post (Toronto, Ontario, Canada)]
5/8
08:00 pm
onvo
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
Medium
Report
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
5/4
02:32 am
onvo
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/26
02:03 am
onvo
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/18
02:03 am
onvo
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/15
08:31 am
onvo
Organovo's fatty liver disease drug meets main goal in mid-stage study [Reuters]
Medium
Report
Organovo's fatty liver disease drug meets main goal in mid-stage study [Reuters]
4/15
08:13 am
onvo
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo [Financial Post (Toronto, Ontario, Canada)
Low
Report
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo [Financial Post (Toronto, Ontario, Canada)
4/15
08:07 am
onvo
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo [Yahoo! Finance]
Medium
Report
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo [Yahoo! Finance]
4/15
08:05 am
onvo
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
High
Report
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
4/10
02:01 am
onvo
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/2
02:04 am
onvo
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Neutral
Report
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/25
02:05 am
onvo
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/17
02:02 am
onvo
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/9
02:07 am
onvo
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.